Figure 2 from BrUOG360: A Phase Ib/II Study of Copanlisib in Combination with Rucaparib in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC)

André Souza; Matthew J. Hadfield; Shaolei Lu; Dragan J. Golijanin; Roxanne Wood; Jeannine Margolis; Kate Anderson; Adam J. Olszewski; Sheldon L. Holder; Wafik S. El‐Deiry; Rahul Aggarwal; Anthony Mega; Benedito A. Carneiro

doi:10.1158/2767-9764.30849277

Abstract

<p>Swimmer plot showing treatment duration on study for all patients. Genomic alterations in the homologous recombination DNA repair and PI3K/AKT/mTOR pathways are noted for each patient.</p>

Related Publications

Olaparib for Metastatic Castration-Resistant Prostate Cancer

Johann S. de Bono , Joaquı́n Mateo , Karim Fizazi +17 more

In men with metastatic castration-resistant prostate cancer who had disease progression while receiving enzalutamide or abiraterone and who had alterations in genes with a role ...

2020 New England Journal of Medicine 2067 citations

Genomic correlates of clinical outcome in advanced prostate cancer

Wassim Abida , Joanna Cyrta , Glenn Heller +40 more

Heterogeneity in the genomic landscape of metastatic prostate cancer has become apparent through several comprehensive profiling efforts, but little is known about the impact of...

2019 Proceedings of the National Academy o... 1301 citations

Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)

Jonathan R. Dry , Sandra Pavey , Christine A. Pratilas +26 more

Abstract Selumetinib (AZD6244, ARRY-142886) is a selective, non–ATP-competitive inhibitor of mitogen-activated protein/extracellular signal–regulated kinase kinase (MEK)-1/2. Th...

2010 Cancer Research 259 citations

Publication Info

Year: 2025
Type: article
Citations: 0
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Figure 2 from BrUOG360: A Phase Ib/II Study of Copanlisib in Combination with Rucaparib in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC)

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

CrossRef

Cite This

APA Style

                            
                                    André Souza, 
                                
                                    Matthew J. Hadfield, 
                                
                                    Shaolei Lu
                                
                                et al.
                            
                            (2025). 
                            Figure 2 from BrUOG360: A Phase Ib/II Study of Copanlisib in Combination with Rucaparib in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC). 
                            
                            .
                            https://doi.org/10.1158/2767-9764.30849277

Identifiers

DOI: 10.1158/2767-9764.30849277

Data Quality

Data completeness: 66%